选择性门静脉栓塞术的理论基础和临床应用

阿力木·阿布都热西提; 邵英梅

doi:10.3969/j.issn.1001-5256.2017.03.040

选择性门静脉栓塞术的理论基础和临床应用

DOI: 10.3969/j.issn.1001-5256.2017.03.040

新疆医科大学第一附属医院消化血管中心肝胆包虫外科

详细信息

中图分类号: R735.7
计量
- 文章访问数: 1886
- HTML全文浏览量: 58
- PDF下载量: 443
- 被引次数: 0
出版历程
- 收稿日期: 2016-11-08
- 出版日期: 2017-03-20

Selective portal vein embolization:theoretical basis and clinical application

Hepatobiliary & Hepatic Hydatid Department of Digestive and Vascular Surgery Centre, First Affiliated Hospital, Xinjiang Medical University

摘要

摘要: 目前,手术切除部分肝叶仍然是治疗肝脏原发性或转移性恶性肿瘤首选和最有效的方法,然而术后残余肝脏容积不足容易发生肝衰竭,影响预后。选择性门静脉栓塞术通过栓塞荷瘤侧门静脉分支,从而使门静脉血流重分配,增加对侧肝组织的门静脉血流,来增加余留肝脏体积。综述了选择性门静脉栓塞术的理论基础及其在临床中的应用,作为肝切除术前的辅助治疗方法,降低术后肝衰竭发生率,提高肿瘤切除率和手术的安全性,使原来无法行手术治疗的患者得到了手术的机会。
- 肝肿瘤 /
- 门静脉栓塞术 /
- 肝切除术 /
- 综述
Abstract: At present, partial hepatolobectomy remains the preferred and most effective treatment method for primary or metastatic malignant liver tumors, but a low future liver remnant (FLR) volume after surgery is the main risk factor for liver failure and may affect patients' prognosis.Through the embolization of the tumor-bearing portal vein branch, selective portal vein embolization (PVE) redistributes the portal vein blood flow and increases portal vein blood flow in the contralateral liver tissue to increase the FLR volume.This article reviews the theoretical basis and clinical application of selective PVE.As an adjuvant therapy before hepatectomy, selective PVE can reduce the incidence rate of postoperative liver failure, increase tumor resection rate and surgical safety, and create the chance for surgery in patients who cannot undergo surgical treatment.
- liver neoplasms /
- portal vein embolization /
- hepatectomy /
- review

HTML全文

参考文献(30)

[1]ROMARIC L, SYLVAIN F, OLIVIER C, et al.Preoperative porta vein embolization in liver cancer:indications, techniques and outcomes[J].Quant Imaging Med Surg, 2015, 5 (5) :730-739.

[2]ROUS P, LARIMORE LD.Relation of the portal blood to liver maintenance:a demonstration of liver atrophy conditional oncompensation[J].J Exp Med, 1920, 31 (5) :609-632.

[3]HONJO I, SUZUKI T, OZAWA K, et al.Ligation of a branch o the portalvein for carcinoma of the liver[J].Am J Surg, 1975, 130 (3) :296-302.

[4]KINOSHITA H, SAKAI K, HIROHASHI K, et al.Preoperativeportal vein embolization for hepatocellular carcinoma[J].World JSurg, 1986, 10 (5) :803-808.

[5]MAKUUCHI M, THAI BL, TAKAYASU K, et al.Preoperativeportal embolization to increase safety of major hepatectomyfor hilar bile duct carcinoma:a preliminary report[J].Surgery, 1990, 107 (5) :521-527.

[6]DIMITRIOS D, PETROS T, SERENA V, et al.Indications, limitations and maneuvers to enable extended hepatectomy:Curren trends[J].World J Gastroenterol, 2014, 20 (24) :7887-7893.

[7]TRESKA V.Methods to increase future liver remnant volume in patients with primarily unresectable colorectal liver metastases:curren state and future perspectives[J].Anticancer Res, 2016, 36 (5) :2065-2071.

[8]BENJAMIN J, MAY MD, DAVID C, et al.Portal vein embolization:rationale, technique, and current application[J].Semin Intervent Radiol, 2012, 29 (2) :81-89.

[9]TAKU A, KEIICHI K.Preoperative portal vein embolization for hepatocellular carcinoma:consensus and controversy[J].World JHepatol, 2016, 8 (9) :439-445.

[10]FIKRI B, ARTHUR P, CAMILO AG, et al.Radioembolisation and portal vein embolization before resection of large hepatocellular carcinoma[J].World J Gastroenterol, 2015, 21 (32) :9666-9670.

[11]ARDITO F, VELLONE M, BARBARO B, et al.Right and extendedright hepatectomies for unilobar colorectal metastases:impact of portal vein embolization on long-term outcome and liver recurrence[J].Surgery, 2013, 153 (6) :801-810.

[12]RONY A, THIERRY DB, RAVI M, et al.Percutaneous transhepatic portal vein embolization:rationale, technique and outcomes[J].Semin Intervent Radiol, 2008, 25 (2) :132-145.

[13]ALBAN D, PIERRE B, NICOLAS D, et al.Quality improvement for portal vein embolization[J].Cardiovasc Intervent Radiol, 2010, 33 (3) :452-456.

[14]ZHU PL, YIN C, FENG JL.Progressin comprehensive treatment of primary liver cancer comprehensive treatment of primary liver cance[J].J Clin Hepatol, 2015, 31 (6) :965-968. (in Chinese) 祝普利, 尹超, 冯建龙.原发性肝癌综合治疗进展[J].临床肝胆病杂志, 2015, 31 (6) :965-968.

[15]RATTI F, SOLDATI C, CATENA M, et al.Role of portal vein embolization in liver surgery:single centre experience in sixty-two patients[J].Updates Surg, 2010, 62 (3-4) :153-159.

[16]WANG JW, ZHANG YM.Research advances in methods for determination of tumor boundary in hepatectomy[J].J Clin Hepal, 2016, 32 (2) :374-377. (in Chinese) 王金伟, 张雅敏.肝切除术中确定肿瘤边界方法的研究进展[J].临床肝胆病杂志, 2016, 32 (2) :374-377.

[17] ZHAO WY, LUO M, WU ZY.A meta-analysis of the effect of portal vein embolization before hepatectomy[C].Collected Papers from the 3rd Congress of the Chinese Chapter of the International Hepato-Pancreato-Biliary Association, 2008, 4:195-198. (in Chinese) 赵文毅, 罗蒙, 吴志勇.肝切除术前门静脉栓塞疗效的meta分析[C].国际肝胆胰协会中国分会第三届学术会议·论文汇编, 2008, 4:195-198.

[18]VALERIE V, ANNIE S, MAGALY Z, et al.Sequential arterial and portal vein embolization in patients with cirrhosis and hepatocellular carcinoma:the hospital beaujon experience[J].Semin Intervent Radiol, 2008, 25 (2) :155-161.

[19]LI HC, LIU P, CHEN SQ, et aI.Clinical effectiveness of preoperative portal vein embolization in the treatment of colorectal cancer liver metastases:a meta-analysis[J].Chin J Exp Surg, 2015, 32 (6) :1418-1420. (in Chinese) 李华驰, 刘佩, 陈双倩, 等.结直肠癌肝转移肝切除术前门静脉栓塞临床疗效的Meta分析[J].中华实验外科杂志, 2015, 32 (6) :1418-1420.

[20]YI B, XU AM, QU ZQ, et al.Preoperative portal vein embolization for hilar cholangiocarcinoma:a report of 16 cases[J].Chin J Prac Surg, 2010, 30 (6) :477-479. (in Chinese) 易滨, 徐爱民, 曲增强, 等.肝门部胆管癌术前行门静脉栓塞16例分析[J].中国实用外科杂志, 2010, 30 (6) :477-479.

[21]ROBIN D, KI M, JAE SK, GO W, et al.Liver regeneration and the atrophy-hypertrophy complex[J].Semin Intervent Radiol, 2008, 25 (2) :92-103.

[22]YOO KY, JI HOON S.Complications of portal vein embolization:evaluation on cross-sectional imaging[J].Korean J Radiol, 2015, 16 (5) :1079-1085.

[23]SCHNITZBAUER AA, LANG SA, GOESSMANN H, et al.Right portal vein ligation combined wiI h in situ splitting induces rapid left lateral liver Iobe hypenrophy enabling 2-staged extended right hepatic resection in small-for-size settings[J].Ann Surg, 2012, 255 (3) :405-414.

[24]SCHADDE E, SCHNITZBAUER AA, TSCHUOR C, et al.Systematic review and meta-analysis of feasibility, safety, and efficacy of a novel procedure:associating liver partition and portal vein ligation for staged hepatectomy[J].Ann surg Oncol, 2015, 22 (9) :3109-3120.

[25]LI J, GIMTTI P, KONIGSRAINER I, et al.ALPPS in right trisectionectomy:a safe purcedure to avoid postoperative liver failure[J].J Gastrointest Surg, 2013, 17 (5) :956-961.

[26]KOKUDO N, SHINDOH J.How can we safely climb the ALPPS[J].Updates Surg, 2013, 65 (3) :175-177.

[27]DENYS A, BIZE P, DEMARTINES N, et al.Quality improvement for portal vein embolization[J].Ardiovasc Intervent Radiol, 2010, 33 (3) :452-456.

[28]ABULKHIR A, LIMONGELLI P, HEALEY AJ, et al.Preoperative portal veinembolization for major liver resection.A meta-analysis[J].Ann Surg, 2008, 247 (1) :49-57.

[29]SONIA TO, KATSUHIRO K, MARK S, et al.Portal vein embolization as an oncosurgical strategy prior to major hepatic resection:anatomic, surgical, and technical considerations[J].Front Surg, 2016, 3 (14) :1-12.

[30]SOUMIL V, SHERAZ M, STEFANO P, et al.Portal vein embolization and ligation for extended hepatectomy[J].Indian J Surg Oncol, 2014, 5 (1) :30-42.

施引文献

资源附件(0)

访问统计